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Understanding Drug Addiction
Through Optogenetics
D. Bird, S. Brown III, T. Hastings, J. Edwards
Physiology and Developmental Biology, Brigham Young University, Provo, UT
Introduction

Methodology

Results - Electrophysiology

Neurosurgery: Using CRE/GFP+ mice, we surgically introduce the
adenovirus rAAV/EF1a-DIO-hChR2-mcherry into the lateral hippocampus
via a nanojet microinjector system. The mice are sedated with a general
anesthetic (isoflurane) and maintained under anesthesia for the duration of
the surgery. A small incision is made on the scalp to expose the skull, where
two access points are then drilled using a Dremel drill. Previous
experimentation and study of mice brains were used to determine the
proper coordinates of the lateral hippocampus. 0.5 micrograms of the virus
are injected into each hemisphere or the brain. The incision is closed with
4-0 silk sutures and the mice are given the opioid buprenorphine for
postoperative pain management. The virus is allowed to incubate for no
less than three weeks, followed by euthanization of host mouse for
experimentation.

Background
Drug addiction results from neural plasticity in the ventral tegmental area
(VTA), an area of the brain’s reward system, in which higher levels of
dopamine are expressed. Research suggests that decreased activity of
inhibitory neurons (specifically, GABAergic neurons) in the VTA could
cause the hyperactivity of dopaminergic cells in the VTA and thus mediate
opiate addiction. However, little additional research has been performed to
evaluate plasticity of VTA GABA neurons and the role they play in
addiction.
Hypothesis
Why are VTA GABAergic cells inhibited and how?
● We hypothesize that inhibitory inputs onto GABA neurons in the VTA
directly affect the degree of dopamine inhibition.
● We additionally hypothesize that GABAergic neurons of the lateral
hypothalamus (LH) are a source input that extends into the VTA and
inhibits VTA GABAergic neurons.
To test our hypotheses, we have isolated GABAergic input sources to the
VTA using optogenetics in mice. Specifically, we have assessed the
plasticity of GABAergic neurons onto VTA GABA cells that receive input
from GABA neurons in the LH, an area that has not been previously studied
with regards to addiction. Identifying plasticity of VTA GABA neurons will
allow us to target new areas involved in opiate addiction.

Fig. 1. Simplified reward pathway within the VTA and LH.
Dopaminergic cells stimulate a reward response while GABAergic cells
inhibit the activity of postsynaptic neurons.

Theta burst

Fig. 3. O-1602 does not appear to increase LTP in GPR55 KO mice, relative to control mice. Effects of O-1602, a potent GPR55 and GPR18 agonist, in GPR55 KO
mice. A) GPR55 KO control (black, n=9) shows no difference in LTP compared to O-1602 (red, n=4). However, some difference in STP is noted, suggesting a potential
presynaptic effect of GPR18. B) O-1602 did not alter basal synaptic transmission, suggesting GPR18 is not basally activated and that O-1602 does not alter transmission by
itself.

Electrophysiology: O-1602 is an agonist for both GPR18 and GPR55, so
to ensure the results would be specific to GPR18 activation, GPR55-/- mice
were used. Coronal slices of GPR55-/- mice were made using a vibratome.
Slices were then incubated for one hour before undergoing
electrophysiological experiments. During experiments, a stable baseline
was first attained, followed by stimulation of slices with a theta burst
conditioning pulse using a bipolar electrode.

Results – Immunohistochemistry (IHC)
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IHC: Transcardial perfusion of paraformaldehyde and subsequent slicing
and staining of the brain will first take place in mice to confirm viral
injection location. With IHC we take coronal slices of the LH that are 20
micrometers thick, and image them using a confocal microscope at 587nm
and 509nm.This allows us to confirm that the virus only infected the LH
region of the brain which we virally injected and that channelrhodopsin
was successfully expressed. Coronal cuts of VTA are also taken to assure
expression of channelrhodopsin in the VTA. Quantification of GAD65
(GFP) and channelrhodopsin (mCherry) is performed with CellSens
programing to determine penetrance of the virus.
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Lateral Hypothalamus (LH)
Trial 1
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GAD67

65

26

141

mCherry

49

59

121

Co-expression

27
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Penetrance

41.54

61.54%
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Ventral Tegmental Area (VTA)
Trial 1

Trial 2

GAD67

177

252

mCherry

85

127

DAPI

120

327

Co-expression

85

127
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48.02%

50.40%

Fig. 2. Infection of the virus and expression of channelrhodopsin (ChR1) is present in the LH. (A) The immunochemistry of GAD67 (GFP) and channelrhodopsin
(mCherry) expression. (B) Axon extensions from GABA-producing neurons in the LH extend into the VTA as indicated by punctate that co-express GAD67 and ChR1.
(C) Quantification of GAD67 and ChR1 expression in the LH shows an average penetrance of 57.53%. Of the GAD67-expressing punctate within the VTA, an average
of 49.21% originate in the LH.

GPR18 is expressed in hippocampus of mice. Cellular expression of
GPR18 occurs largely in the pyramidal layer of the hippocampus and
occasionally in interneurons.
Application of the GPR18 agonist O-1602 (5 µM) to GPR55 knockout
mice does not enhance LTP in GPR55 KO mouse brain slices. It also
does not seem to alter synaptic transmission.

Future Research
Optogenetics: Research trials using optogenetics will continue in order to
assess the effect of LH GABAergic neurons on VTA GABAergic neurons.
Opioid trials: After optogenetic testing, we will run opioid agonist trials to
determine how opioids might affect inhibitory GABA neurons in the lateral
hypothalamus.
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